During the Aug. 26 meeting of the Menlo Park-based BioScience Business Round Table, one speaker described the lack of VC funding as 'Armageddon' for biotech startups, blaming the problem partly on increased regulatory drag on the drug-approval process. The Mercury News reports. Related post regarding Bio in TN is here.
Sunday, August 30, 2009
Biotech innovation threatened (SJMN)
During the Aug. 26 meeting of the Menlo Park-based BioScience Business Round Table, one speaker described the lack of VC funding as 'Armageddon' for biotech startups, blaming the problem partly on increased regulatory drag on the drug-approval process. The Mercury News reports. Related post regarding Bio in TN is here.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment